From July 1, 2022 to December 31, 2022, the company has repurchased 12,078,000 shares, representing 2.94% for HKD 18.44 million. With this, the company has completed the repurchase of 13,412,000 shares, representing 3.28% for HKD 20.54 million under the buyback announced on June 24, 2022.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |